“Interleukin 22 (IL-22) As Biomarker For Rheumatoid Arthritis In Iraqi Population”. 2022. Journal of Pharmaceutical Negative Results, October, 209-12. https://doi.org/10.47750/pnr.2022.13.S02.29.